Ondine Biomedical, Inc. (GB:OBI) has released an update.
Ondine Biomedical Inc. has announced its 2024 AGM to be held virtually on June 28, where shareholders will vote on director re-elections and the re-appointment of PricewaterhouseCoopers LLP as auditors. Shareholders are urged to vote by proxy ahead of the AGM, with results to be published post-meeting. The company also noted an upcoming release regarding its full year results and annual report.
For further insights into GB:OBI stock, check out TipRanks’ Stock Analysis page.
